Logo image of PHG

KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PHG - US5004723038

27.11 USD
+0.13 (+0.48%)
Last: 12/26/2025, 8:09:56 PM
27.11 USD
0 (0%)
After Hours: 12/26/2025, 8:09:56 PM
Fundamental Rating

4

Overall PHG gets a fundamental rating of 4 out of 10. We evaluated PHG against 185 industry peers in the Health Care Equipment & Supplies industry. While PHG is still in line with the averages on profitability rating, there are concerns on its financial health. PHG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PHG was profitable.
PHG had a positive operating cash flow in the past year.
In multiple years PHG reported negative net income over the last 5 years.
PHG had a positive operating cash flow in 4 of the past 5 years.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

PHG's Return On Assets of 0.61% is fine compared to the rest of the industry. PHG outperforms 73.51% of its industry peers.
The Return On Equity of PHG (1.56%) is better than 74.59% of its industry peers.
The Return On Invested Capital of PHG (4.49%) is better than 75.14% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.49%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Profit Margin, with a value of 0.91%, PHG is in the better half of the industry, outperforming 73.51% of the companies in the same industry.
PHG's Operating Margin of 6.11% is fine compared to the rest of the industry. PHG outperforms 71.35% of its industry peers.
PHG's Operating Margin has declined in the last couple of years.
PHG has a worse Gross Margin (43.85%) than 63.24% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
Compared to 1 year ago, PHG has less shares outstanding
Compared to 5 years ago, PHG has more shares outstanding
Compared to 1 year ago, PHG has a worse debt to assets ratio.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 1.89 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.89, PHG is in line with its industry, outperforming 57.84% of the companies in the same industry.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHG (19.41) is better than 71.35% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.89
ROIC/WACC0.68
WACC6.57%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PHG has a Current Ratio of 1.26. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
PHG has a worse Current ratio (1.26) than 82.70% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, PHG is doing worse than 83.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

PHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -0.81% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

Based on estimates for the next years, PHG will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.05% on average per year.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.41% yearly.
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.58, which indicates a correct valuation of PHG.
Based on the Price/Earnings ratio, PHG is valued cheaply inside the industry as 87.57% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PHG to the average of the S&P500 Index (26.57), we can say PHG is valued slightly cheaper.
PHG is valuated correctly with a Price/Forward Earnings ratio of 14.90.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 87.57% of the companies listed in the same industry.
PHG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.58
Fwd PE 14.9
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHG is valued cheaply inside the industry as 87.03% of the companies are valued more expensively.
PHG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHG is cheaper than 73.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.03
EV/EBITDA 12
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.99
PEG (5Y)N/A
EPS Next 2Y5.55%
EPS Next 3Y8.25%

6

5. Dividend

5.1 Amount

PHG has a Yearly Dividend Yield of 4.25%, which is a nice return.
Compared to an average industry Dividend Yield of 0.20, PHG pays a better dividend. On top of this PHG pays more dividend than 98.92% of the companies listed in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 4.25%

5.2 History

The dividend of PHG decreases each year by -70.49%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

PHG pays out 0.62% of its income as dividend. This is a sustainable payout ratio.
DP0.62%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (12/26/2025, 8:09:56 PM)

After market: 27.11 0 (0%)

27.11

+0.13 (+0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners44.69%
Inst Owner Change-2.3%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.11B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price TargetN/A
Short Float %0.22%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield 4.25%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13 2025-05-13 (0.9673)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)2.1%
PT rev (3m)-0.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.38%
EPS NY rev (1m)3.66%
EPS NY rev (3m)2.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 15.58
Fwd PE 14.9
P/S 1.24
P/FCF 51.03
P/OCF 20.15
P/B 2.13
P/tB N/A
EV/EBITDA 12
EPS(TTM)1.74
EY6.42%
EPS(NY)1.82
Fwd EY6.71%
FCF(TTM)0.53
FCFY1.96%
OCF(TTM)1.35
OCFY4.96%
SpS21.86
BVpS12.7
TBVpS-2.08
PEG (NY)3.99
PEG (5Y)N/A
Graham Number22.3
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.49%
ROICexc 4.97%
ROICexgc 16.33%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.89
F-Score8
WACC6.57%
ROIC/WACC0.68
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y3.9%
EPS Next 2Y5.55%
EPS Next 3Y8.25%
EPS Next 5Y13.05%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-1.88%
Revenue Next 2Y0.58%
Revenue Next 3Y1.85%
Revenue Next 5Y3.41%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.79%
EBIT Next 3Y20.32%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


What is the valuation status for PHG stock?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.


What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 15.58 and the Price/Book (PB) ratio is 2.13.


What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 3.9% in the next year.